Jonathan Schneck, co-director of the Johns Hopkins Center for Translational Immunoengineering and professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine  was invited to attend the Johns Hopkins Global Biotechnology Innovation Summit to discuss partnerships with South Korean leaders. During the trip, Schneck also met with Incheon mayor Yoo Jeong-bok to discuss joint biotechnology research and development opportunities based in Incheon.

Man is business suite standing on a stage giving a Power Point presentation to an audience sitting at several round tables.

Jonathan Schneck presents research at the 2025 Global Biotechnology Innovation Summit in South Korea.